|
TSAd
Could be a T-cell-specific adapter protein involved in the control of T-cell activation. May play a role in the CD4-p56-LCK-dependent signal transduction pathway. Could also play an important role in normal and pathological angiogenesis. Could be an adapter protein that facilitates and regulates interaction of KDR with effector proteins important to endothelial cell survival and proliferation. Expression limited to tissues of the immune system and, in particular, activated T-cells. Expressed in peripheral blood leukocytes, thymus and spleen. Much lower expression or undetectable, in brain, placenta, skeletal muscle, prostate, testis, ovary, small intestine, and colon. Expressed at low levels in unstimulated T-cells, but not expressed in normal resting or activated B-cells. According to PubMed:10692392, expression is not restricted to activated T-cells, but strongly expressed in blood cell lineages, the endothelium and other cell and tissue types, such as heart, lung, and liver. 4 alternatively spliced human isoforms have been reported. Note: This description may include information from UniProtKB.
|
| Protein type: Adaptor/scaffold |
| Chromosomal Location of human Ortholog: 1q23.1 |
|
Cellular Component:
cytoplasm; cytosol
|
|
Molecular Function:
protein binding; SH3 domain binding
|
|
Biological Process:
angiogenesis; cell differentiation; signal transduction; T cell proliferation
|
|
Reference #:
Q9NP31
(UniProtKB)
|
|
Alt. Names/Synonyms: F2771; SCAP; SH2 domain containing 2A; SH2 domain protein 2A; SH2 domain-containing adapter protein; SH2 domain-containing protein 2A; SH22A; SH2D2A; T cell specific adapter protein TSAd; T cell-specific adapter protein; T lymphocyte specific adaptor protein; TSAD; VEGF receptor-associated protein; VRAP
|
|
Gene Symbols: SH2D2A
|
|
Molecular weight:
42,934 Da
|
|
Basal Isoelectric point:
6.96
Predict pI for various phosphorylation states
|
|
CST Pathways:
ErbB/HER Signaling
|
|
| Select Structure to View Below |
TSAd
|
|
|